DSG3 and acquired polycythemia vera: Preclinical studies in a mouse model of pemphigus vulgaris (PV) have demonstrated that CAAR-T cells expressing the PV autoantigen Dsg-3 effectively deplete pathogenic B cells and induce long-term clinical improvements in PV symptoms [98,100].